Title: HB 2827 Text
Official Title: 
Number of Sections: 1
Source: versions - Introduced Version
Media Type: text/html

================================================================================

Section 1:
HB 2827 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version House Bill 2827 History |  Email Key: Green = existing Code. Red = new code to be enacted WEST virginia legislature2025 regular session FISCAL NOTE IntroducedHouse Bill 2827By Delegate Young[Introduced February 24, 2025; referred to the Committee on Health and Human Resources then Government Organization]A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new article, designated §9-11-1, §9-11-2, §9-11-3, §9-11-4, and §9-11-5, relating to creating  the wholesale importation of prescription drugs program; providing definitions; design requirements of the program; implementation of the program by the West Virginia Department of Health and Human Resources; and requiring the department to report annually to the Legislative Oversight Commission on Health and Human Resources Accountability.Be it enacted by the Legislature of West Virginia: ARTICLE 11. WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM. §9-11-1. Authorization. The Wholesale Prescription Drug Importation Program referred to in this article is established to provide for the wholesale importation of prescription drugs from Canada by or on behalf of the state. The program must be designed in accordance with the requirements of this article. The program may not be implemented unless the state obtains approval and certification from the United States Department of Health and Human Services pursuant to 21 U.S.C. § 384(l). §9-11-2. Definitions. As used in this article: "Department" means the West Virginia Department of Health and Human Resources."Program" means the Wholesale Prescription Drug Importation Program. §9-11-3. Design of program. (a) Design requirements. —The department, in consultation with appropriate federal and other state agencies, other states and interested parties, shall design the program to comply with the applicable requirements of 21 U.S.C. § 384, including requirements regarding safety and cost savings. The program design shall:(1) Provide that the department become a licensed drug wholesaler or contract with a licensed drug wholesaler in order to seek federal certification and approval, pursuant to 21 U.S.C. § 384, to import safe prescription drugs and provide cost savings to consumers in the state;(2) Use prescription drug suppliers in Canada regulated under the laws of Canada or of one or more Canadian provinces, or both;(3) Ensure that only prescription drugs meeting the federal Food and Drug Administration's safety, effectiveness and other standards are imported by or on behalf of the state;(4) Import only those prescription drugs expected to generate substantial cost savings for consumers in the state;(5) Ensure that the program complies with the transaction and tracing requirements of 21 U.S.C. §§360eee and §360eee-1 to the extent feasible and practical prior to imported prescription drugs coming into the possession of the licensed drug wholesaler and that the program complies fully with those federal requirements after imported prescription drugs are in the possession of the licensed drug wholesaler;(6) Consider whether the program may be developed on a multistate basis through collaboration with other states;(7) Prohibit the distribution, dispensing, or sale of imported prescription drugs outside of the state;(8) Recommend a charge per prescription or another method of financing to ensure that the program is adequately funded in a manner that does not jeopardize significant cost savings to consumers, including adequate funding for the initial start-up costs of the program;(9) Apply for and receive funds, grants, or contracts from public and private sources; and(10) Include an audit function.(b) Rules. —The department shall propose rules for legislative approval pursuant to §29B-3-1 et seq., to design the program in accordance with the requirements of subsection (a) of this section no later than January 1, 2026.(c) Request for federal approval and certification. —The department shall submit a request for approval and certification of the program to the United States Department of Health and Human Services no later than April 1, 2026. §9-11-4. Implementation. (a) Implementation; operation. — Upon receipt of federal approval and certification under 21 U.S.C. § 384, the department shall implement the program as required in subsection (b). The program must begin operating no later than six months following receipt of federal approval and certification.(b) Requirements. — Prior to operating the program, the department shall:(1) Become a licensed drug wholesaler or enter into a contract with a licensed drug wholesaler in the state;(2) Contract with one or more distributors licensed in the state;(3) Contract with one or more licensed and regulated prescription drug suppliers in Canada;(4) Consult with health insurance carriers, employers, pharmacies, pharmacists, health care providers, and consumers;(5) Develop a registration process for health insurance carriers, pharmacies, and health care providers, authorized to prescribe and administer prescription drugs, that are willing to participate in the program;(6) Create a publicly accessible website for listing the prices of prescription drugs to be imported under the program;(7) Create an outreach and marketing plan to generate public awareness of the program;(8) Provide a telephone hotline to answer questions and address needs of consumers, employers, health insurance carriers, pharmacies, health care providers, and others affected by the program;(9) Develop a two-year audit work plan; and(10) Conduct any other activity determined necessary to successfully implement and operate the program. §9-11-5. Annual reporting. Beginning December 1, 2026, and annually until 2030, the department shall report to the Legislative Oversight Commission on Health and Human Resources Accountability regarding the implementation and operation of the program during the previous calendar year, including:(1) Prescription drugs included. —The prescription drugs included in the program;(2) Participation. —The number of participating pharmacies, health care providers, and health insurance carriers;(3) Prescriptions dispensed. —The number of prescription drugs dispensed through the program;(4) Estimated savings. — The estimated cost savings to consumers, health insurance carriers, employers, and the state during the previous calendar year and to date;(5) Audit findings. — Information regarding implementation of the audit work plan and audit findings; and(6) Other relevant information. — Any other information the department considers relevant. NOTE: The purpose of this bill is to establish the Wholesale Prescription Drug Importation Program for the purpose of importing drugs from Canada on behalf of the state. The program will operate in compliance with the federal Department of Health and Human Services (HHS) regulations governing importation of prescription drugs and with approval of the secretary of HHS.Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone:


================================================================================

Raw Text:
HB 2827 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version House Bill 2827 History |  Email Key: Green = existing Code. Red = new code to be enacted WEST virginia legislature2025 regular session FISCAL NOTE IntroducedHouse Bill 2827By Delegate Young[Introduced February 24, 2025; referred to the Committee on Health and Human Resources then Government Organization]A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new article, designated §9-11-1, §9-11-2, §9-11-3, §9-11-4, and §9-11-5, relating to creating  the wholesale importation of prescription drugs program; providing definitions; design requirements of the program; implementation of the program by the West Virginia Department of Health and Human Resources; and requiring the department to report annually to the Legislative Oversight Commission on Health and Human Resources Accountability.Be it enacted by the Legislature of West Virginia: ARTICLE 11. WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM. §9-11-1. Authorization. The Wholesale Prescription Drug Importation Program referred to in this article is established to provide for the wholesale importation of prescription drugs from Canada by or on behalf of the state. The program must be designed in accordance with the requirements of this article. The program may not be implemented unless the state obtains approval and certification from the United States Department of Health and Human Services pursuant to 21 U.S.C. § 384(l). §9-11-2. Definitions. As used in this article: "Department" means the West Virginia Department of Health and Human Resources."Program" means the Wholesale Prescription Drug Importation Program. §9-11-3. Design of program. (a) Design requirements. —The department, in consultation with appropriate federal and other state agencies, other states and interested parties, shall design the program to comply with the applicable requirements of 21 U.S.C. § 384, including requirements regarding safety and cost savings. The program design shall:(1) Provide that the department become a licensed drug wholesaler or contract with a licensed drug wholesaler in order to seek federal certification and approval, pursuant to 21 U.S.C. § 384, to import safe prescription drugs and provide cost savings to consumers in the state;(2) Use prescription drug suppliers in Canada regulated under the laws of Canada or of one or more Canadian provinces, or both;(3) Ensure that only prescription drugs meeting the federal Food and Drug Administration's safety, effectiveness and other standards are imported by or on behalf of the state;(4) Import only those prescription drugs expected to generate substantial cost savings for consumers in the state;(5) Ensure that the program complies with the transaction and tracing requirements of 21 U.S.C. §§360eee and §360eee-1 to the extent feasible and practical prior to imported prescription drugs coming into the possession of the licensed drug wholesaler and that the program complies fully with those federal requirements after imported prescription drugs are in the possession of the licensed drug wholesaler;(6) Consider whether the program may be developed on a multistate basis through collaboration with other states;(7) Prohibit the distribution, dispensing, or sale of imported prescription drugs outside of the state;(8) Recommend a charge per prescription or another method of financing to ensure that the program is adequately funded in a manner that does not jeopardize significant cost savings to consumers, including adequate funding for the initial start-up costs of the program;(9) Apply for and receive funds, grants, or contracts from public and private sources; and(10) Include an audit function.(b) Rules. —The department shall propose rules for legislative approval pursuant to §29B-3-1 et seq., to design the program in accordance with the requirements of subsection (a) of this section no later than January 1, 2026.(c) Request for federal approval and certification. —The department shall submit a request for approval and certification of the program to the United States Department of Health and Human Services no later than April 1, 2026. §9-11-4. Implementation. (a) Implementation; operation. — Upon receipt of federal approval and certification under 21 U.S.C. § 384, the department shall implement the program as required in subsection (b). The program must begin operating no later than six months following receipt of federal approval and certification.(b) Requirements. — Prior to operating the program, the department shall:(1) Become a licensed drug wholesaler or enter into a contract with a licensed drug wholesaler in the state;(2) Contract with one or more distributors licensed in the state;(3) Contract with one or more licensed and regulated prescription drug suppliers in Canada;(4) Consult with health insurance carriers, employers, pharmacies, pharmacists, health care providers, and consumers;(5) Develop a registration process for health insurance carriers, pharmacies, and health care providers, authorized to prescribe and administer prescription drugs, that are willing to participate in the program;(6) Create a publicly accessible website for listing the prices of prescription drugs to be imported under the program;(7) Create an outreach and marketing plan to generate public awareness of the program;(8) Provide a telephone hotline to answer questions and address needs of consumers, employers, health insurance carriers, pharmacies, health care providers, and others affected by the program;(9) Develop a two-year audit work plan; and(10) Conduct any other activity determined necessary to successfully implement and operate the program. §9-11-5. Annual reporting. Beginning December 1, 2026, and annually until 2030, the department shall report to the Legislative Oversight Commission on Health and Human Resources Accountability regarding the implementation and operation of the program during the previous calendar year, including:(1) Prescription drugs included. —The prescription drugs included in the program;(2) Participation. —The number of participating pharmacies, health care providers, and health insurance carriers;(3) Prescriptions dispensed. —The number of prescription drugs dispensed through the program;(4) Estimated savings. — The estimated cost savings to consumers, health insurance carriers, employers, and the state during the previous calendar year and to date;(5) Audit findings. — Information regarding implementation of the audit work plan and audit findings; and(6) Other relevant information. — Any other information the department considers relevant. NOTE: The purpose of this bill is to establish the Wholesale Prescription Drug Importation Program for the purpose of importing drugs from Canada on behalf of the state. The program will operate in compliance with the federal Department of Health and Human Services (HHS) regulations governing importation of prescription drugs and with approval of the secretary of HHS.Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone: